Denmark must play role in EU reference lab endgame, says chamber of commerce

The EU will soon make a decision on reference labs required by its new regulation, IVDR. Denmark should be a contender, says the Danish Chamber of Commerce, highlighting benefits.


Distribution of the EU’s reference labs should soon be known.

Shortly before summer, the EU’s new In Vitro Diagnostic Medical Devices Regulation (IVDR) came into force, which tightened requirements for firms, importers, and distributors of IVDs, which include testing diagnostics devices for pregnancies, blood sugar levels, HIV, Covid-19, and much more.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Jefferies spots weaknesses in GN

One potential chink in GN’s armor is that the company’s newly announced hearing aid platform, Omnia, isn’t predicted to win significant market shares.

FDA fast-tracks Eli Lilly's obesity candidate

Tirzepatide is already approved for type 2 diabetes, and Lilly has been vying for access to the obesity market for a while – the day the drug could be approved in both indications has now been moved up.

Further reading

Related articles

Latest news

See all jobs